Bicnu is a medicine containing the active ingredient(s) carmustine. On this page you will find out more about Bicnu, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: carmustine
Information for medicine and pack size:
Bicnu (10 x 100 mg vials, 10 x 3 mL inert diluent vials), 1 pack
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
INDICATIONS AS AT 16 DECEMBER 1985: Carmustine is indicated as palliative therapy as a single agent or in established combination therapy with other approved chemotherapeutic agents in the following: 1. Malignant Glioma. 2. Multiple Myeloma: In combination with prednisone. 3. Hodgkin's Disease: As secondary therapy in combination with other approved drugs in patients who relapse while being treated with primary therapy, or who fail to respond to primary therapy. 4. Non-Hodgkins lymphomas: As secondary therapy in combination with other approved drugs for patients who relapse while being treated with primary therapy or who fail to respond to primary therapy.
Table of characteristics
1 vial of powder - 100mg each: Prescription Only Medicine, or Prescription Animal Remedy
10 vials of powders - 100mg each: Prescription Only Medicine, or Prescription Animal Remedy
1 vial of diluent - 3mL each: Not scheduled. Not considered by committee
10 vials of diluent - 3mL each: Not scheduled. Not considered by committee
|Visual appearance||Pale yellow powder|
|Dosage Form||Injection, powder for|
|Route of administration||Intravenous|
|Visual appearance||Clear colourless liquid|
|Dosage Form||Diluent, not applicable|
|Route of administration||Intravenous|
There is one type of pack available.
Pack type 1
|Storage temperature||Store at 2 to 8 degrees Celsius|
|Storage conditions||Do not Freeze,Refrigerate|
|Life time||36 Months|
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.
Found 2 results
BiCNU | myVMC
Carmustine is used in the palliative management, alone or in combination with other agents, of the following cancers: malignant glioma (type of brain tumour) multiple myeloma (often in combination with prednisone) Hodgkins disease Non-Hodgkins lymphoma The implantable preparation of Carmustine, Gliadel Implant, is used to prolong life in patients with recurrent glioblastoma multiforme (a malignant brain tumour) who have had surgery
Read more on myVMC – Virtual Medical Centre website
BiCNU Powder for injection - myDr.com.au
BiCNU Powder for injection - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Found 0 results